Novavax Stock (NASDAQ: NVAX) stock price, news, charts, stock research, profile.
|Vol / Avg.4.514M / 7.803M||Mkt Cap671.165M|
|Day Range5.531 - 5.770||52 Wk Range5.300 - 18.550|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|2023-08-10||HC Wainwright & Co.||Vernon Bernardino||Reiterates||BuyBuy||Maintains||-||35.00|
|2023-08-09||B. Riley Securities||Mayank Mamtani||Upgrades||NeutralBuy||Announces||-||15.00|
|2023-05-10||HC Wainwright & Co.||Vernon Bernardino||Reiterates||Buy||Lowers||110.00||35.00|
|2023-03-01||B. Riley Securities||Mayank Mamtani||Downgrades||BuyNeutral||Lowers||29.00||10.00|
|Ticker||Company||Chg %||Mkt Cap|
|FDMT||4D Molecular Therapeutics||-2.49%||622.8M|
You can purchase shares of Novavax (NASDAQ: NVAX) through any online brokerage.
The latest price target for Novavax (NASDAQ: NVAX) was reported by HC Wainwright & Co. on Thursday, August 10, 2023. The analyst firm set a price target for 35.00 expecting NVAX to rise to within 12 months (a possible 519.47% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Novavax (NASDAQ: NVAX) is $5.65 last updated Today at December 11, 2023 at 7:24 PM UTC.
There is no dividend information for Novavax.
Novavax’s Q4 earnings are confirmed for Tuesday, February 27, 2024.
There is no upcoming split for Novavax.
Novavax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.